Ligand validation:5WF6

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 5WF6 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5WF6_OLC_A_1202	11%	60%	0.287	0.918	0.52	0.98	-	-	2	0	36%	0.36
3QAK_OLC_A_1201	24%	33%	0.139	0.858	1.51	1.15	1	2	0	0	48%	0.48
8JWZ_OLC_A_521	19%	54%	0.212	0.807	0.8	0.97	2	1	0	0	100%	1
5WF5_OLC_A_1202	9%	61%	0.273	0.83	0.51	0.97	-	1	0	0	60%	0.6
8JWY_OLC_A_1219	7%	43%	0.313	0.768	0.98	1.24	1	2	1	0	100%	1
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	0	100%	1
4N6H_OLC_A_1222	63%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	0.88
5IU4_OLC_A_2429	61%	59%	0.136	0.926	0.8	0.78	2	1	1	0	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	0	100%	1
7B0O_OLC_A_302	59%	54%	0.146	0.929	0.69	1.07	1	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.